Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1056 | 982 | 1222 | 979 | 1340 | 1606 |
Fund Return | 5.59% | -1.79% | 22.16% | -0.71% | 6.03% | 4.85% |
Place in category | 61 | 47 | 59 | 57 | 58 | 35 |
% in Category | 71 | 63 | 64 | 71 | 72 | 75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 36.07B | 11.29 | 5.66 | 10.62 | ||
T. Rowe Price Blue Chip Growth | 33.1B | 28.40 | 5.04 | 14.38 | ||
T. Rowe Price Capital AppreciationI | 29.62B | 11.42 | 5.79 | - | ||
T. Rowe Price Blue Chip Growth I | 30.35B | 28.53 | 5.18 | - | ||
T. Rowe Price Instl Large Cap Growt | 23.06B | 24.63 | 5.87 | 15.66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard European Stock Index Adm | 4.88B | 6.55 | 2.61 | 5.46 | ||
Fidelity Europe | 543.93M | 6.90 | -1.80 | 4.74 | ||
Vanguard European Stock Index I | 845.08M | 6.58 | 2.64 | 5.48 | ||
DFA Continental Small Company I | 577.31M | 4.74 | -0.83 | 7.81 | ||
Brown Advisory WMC Strat Eurp Eq In | 334.3M | 12.81 | 6.16 | 8.03 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.89 | 780.0 | -0.29% | |
ASML Holding | NL0010273215 | 4.30 | 683.50 | +0.83% | |
SAP | DE0007164600 | 3.87 | 241.700 | +3.76% | |
AstraZeneca | GB0009895292 | 3.41 | 10,480.0 | -2.87% | |
Unilever | GB00B10RZP78 | 2.83 | 56.36 | -0.35% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Neutral | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Neutral | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review